Invention Grant
- Patent Title: 2-iminobiotin for use in the treatment of brain cell injury
-
Application No.: US16060005Application Date: 2016-12-16
-
Publication No.: US10525039B2Publication Date: 2020-01-07
- Inventor: Paul Willem Theresia Josef Leufkens , Cacha Marie Petronelle Catherine Dorothee Peeters , Huibert Alexander Tjabbes
- Applicant: Neurophyxia B.V.
- Applicant Address: NL 's-Hertogenbosch
- Assignee: Neurophyxia B.V.
- Current Assignee: Neurophyxia B.V.
- Current Assignee Address: NL 's-Hertogenbosch
- Agency: TraskBritt
- Priority: EP15200492 20151216
- International Application: PCT/NL2016/050880 WO 20161216
- International Announcement: WO2017/105237 WO 20170622
- Main IPC: A61K31/4164
- IPC: A61K31/4164 ; A61K31/4188 ; G01N33/68 ; A61K9/00 ; A61P25/00
Abstract:
The present disclosure relates to the use of 2-iminobiotin for treating brain cell injury, in particular in adults. The treatment may be used for the treatment of cerebral hypoxia-ischemia and/or reperfusion injury, including one or more symptoms thereof. Provided are methods of treatment comprising administering a therapeutically effective dose of 2-iminobiotin to an individual in need thereof.
Public/Granted literature
- US20190262316A1 2-IMINOBIOTIN FOR USE IN THE TREATMENT OF BRAIN CELL INJURY Public/Granted day:2019-08-29
Information query
